828243-30-7 Usage
Uses
Used in Organic Synthesis:
3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)BENZOIC ACID is used as a building block for the synthesis of various chemical compounds due to its versatile structure and functional groups.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)BENZOIC ACID is used as a precursor for the development of pharmaceuticals, leveraging its unique structure to create biologically active molecules.
Used in Chemical Research:
3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)BENZOIC ACID is utilized as a research compound to explore new synthetic pathways and to understand the reactivity and properties of related chemical entities.
Used in Drug Development:
3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)BENZOIC ACID is employed as a key intermediate in the process of drug development, contributing to the discovery and optimization of new therapeutic agents.
Used in the Pharmaceutical Industry:
Within the pharmaceutical industry, 3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)BENZOIC ACID is used as a synthetic intermediate for the preparation of diverse pharmaceuticals, taking advantage of its Boc protecting group for selective functionalization and the subsequent development of drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 828243-30-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,8,2,4 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 828243-30:
(8*8)+(7*2)+(6*8)+(5*2)+(4*4)+(3*3)+(2*3)+(1*0)=167
167 % 10 = 7
So 828243-30-7 is a valid CAS Registry Number.
828243-30-7Relevant academic research and scientific papers
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities
Tang, Haifeng,Yan, Yan,Feng, Zhe,De Jesus, Reynalda K.,Yang, Lihu,Levorse, Dorothy A.,Owens, Karen A.,Akiyama, Taro E.,Bergeron, Raynald,Castriota, Gino A.,Doebber, Thomas W.,Ellsworth, Kenneth P.,Lassman, Michael E.,Li, Cai,Wu, Margaret S.,Zhang, Bei B.,Chapman, Kevin T.,Mills, Sander G.,Berger, Joel P.,Pasternak, Alexander
scheme or table, p. 6088 - 6092 (2010/11/18)
A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes.
